维普期刊资源整合服务平台（V6.5）

78篇 您的检索式：作者名="Hylemon"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation显示文摘	Jasmohan S. Bajaj Phillip B. Hylemon Jason M. Ridlon Douglas M. Heuman Kalyani Daita Melanie B. White Pamela Monteith Nicole A. Noble Masoumeh Sikaroodi Patrick M. Gillevet	2012	AJP: Gastrointestinal and Liver Physiology2012，，6：	3
2	Modulation of the fecal bile acid profile by gut microbiota in cirrhosis显示文摘	Genta Kakiyama William M. Pandak Patrick M. Gillevet Phillip B. Hylemon Douglas M. Heuman Kalyani Daita Hajime Takei Akina Muto Hiroshi Nittono Jason M. Ridlon Melanie B. White Nicole A. Noble Pamela Monteith Michael Fuchs Leroy R. Thacker Masoumeh Sikaro	2013	Journal of Hepatology2013，，5：	3
3	Activation of the Raf-1/MEK/ERK cascade by bile acids occurs via the epidermal growth factor receptor in primary rat hepatocytes显示文摘	Yi-Ping Rao Elaine J. Studer R.Todd Stravitz Seema Gupta Liang Qiao Paul Dent Phillip B. Hylemon	2002	Hepatology2002，，2：	2
4	显示文摘	Pandak WM Hylemon PB Ren S	2002	Hepatology2002，35，6：	1
5	Identification of a novel sulfonated oxysterol,5-cholesten-3beta,25-diol 3-sulfonate,in hepatocyte nuclei and mitochondria显示文摘	Ren S Hylemon P Zhang ZP	2006	J Lipid Res2006，47，5：	1
6	Regulation of bile acid synthesis显示文摘	Vlahcevic ZR Heuman DM Hylemon PB	1991	Hepatology1991，13，3：	1
7	Overexpression of cholesterol transporter StAR increases in vivo rates of bile acid synthesis in the rat and mouse显示文摘	Ren S Hylemon PB Marques D	2004	Hepatology2004，40，4：	1
8	Bile salt biotransformations by human intestinal bacteria显示文摘	Ridlon J M gang D J Hylemon P B	2006	J Lipid Res2006，47，2：	1
9	Randomised clinical trial: Lactobacillus GG modulates gut mierobiome, metabolome and endotoxemia in patients with cirrhosis 显示文摘	Bajaj JS Heuman DM Hylemon PB	2014	Aliment Pharrnacol Ther2014，39，：	1
10	Effect of increasing the expression of cholesterol transporters (StAR,MLN64,and SCP-2) on bile acid synthesis显示文摘	Ren S Hylemon P Marques D	2004	J Lipid Res2004，45，11：	1
11	Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis显示文摘	Bajaj JS Heuman DM Hylemon PB	2014	Aliment Pharma- col & Therapeut2014，39，10：	1
12	Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver显示文摘	Lombard C McKalhp R J Hylemon PB	2003	Clin Immunol2003，109，2：	1
13	Cirrhosis, bile acids and gut microbiota显示文摘	Jason M Ridlon Joao Marcelo Alves Phillip B Hylemon Jasmohan S Bajaj	2013	Gut Microbes2013，，5：	1
14	Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver显示文摘	Lombard C McKallip RJ Hylemon PB	2003	Clin Immunol2003，109，2：	1
15	Bile acids as regulatory mole- eules显示文摘	Hylemon PB Zhou H Pandak WM	2009	Lipid Res2009，50，：	1
16	Bile acids as regulatory mol- ecules显示文摘	Hylemon PB Zhou H Pandak WM	2009	Lipid Res2009，50，：	1
17	Bile acids as Reg- ulatory molecules显示文摘	Hylemon PB Zhou H Pandak W M etal	2009	Lipid Res2009，50，：	1
18	A potential role for resistant starch fermentation in modulating colonic bacterial metabolism and colon cancer risk显示文摘	RIDLON J M HYLEMON P B	2006	Cancer Biol Ther2006，5，3：	1
19	LXRa is the dominant regulator of CYP7A1 transcription显示文摘	Gupta S Pandak WM Hylemon PB	2002	J Biochemical and Biophysical Research Communications2002，293，1：	1
20	Sulfation of 25-hydroxycholesterol by SULT2B1b decreases cellular lipids via the LXR/SREBP-1c signaling pathway in human aortic endothelial cells显示文摘	Qianming Bai Leyuan Xu Genta Kakiyama Melissa Ann Runge-Morris Phillip B. Hylemon Lianhua Yin William M. Pandak Shunlin Ren	2010	Atherosclerosis2010，，2：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示